Skip to main content
. 2022 Feb 21;57(5):1191–1200. doi: 10.1111/1475-6773.13936

TABLE 2.

Estimated effect of the eLTC program on service use and spending outcomes among long‐term care beneficiaries

Treatment group mean (N = 7194) Comparison group mean (N = 19,713) Estimated effect (SE) Percent effect p‐value
Total Medicare expenditures ($ PBPM)
Baseline year 1987 2148
Follow‐up year 1 2109 2351 −81* (44) −3.7% 0.07
Follow‐up year 2 1855 2105 −89* (53) −4.6% 0.09
Cumulative 1970 2204 −73* (42) −3.6% 0.08
Hospital stays (per 1000 beneficiaries)
Baseline year 805 888
Follow‐up year 1 793 880 −4.1 (20) −0.5% 0.84
Follow‐up year 2 738 855 −35 (25) −4.5% 0.17
Cumulative 753 845 −9.9 (19) −1.3% 0.60
ED and observation visits (per 1000 beneficiaries)
Baseline year 814 831
Follow‐up year 1 779 871 −75*** (22) −8.8% <0.01
Follow‐up year 2 757 841 −66** (28) −8.0% 0.02
Cumulative 772 863 −73*** (21) −8.6% <0.01
Likelihood of readmission within 30 days of hospital discharge (percentage)
Baseline year 18 18
Follow‐up year 1 22 22 −1.0 (1.0) −4.3% 0.30
Follow‐up year 2 18 18 −0.89 (1.4) −4.7% 0.52
Cumulative 21 21 −0.98 (0.94) −4.5% 0.30

Note: Estimated effects for expenditures and number of visits or stays are based on a difference‐in‐differences approach and show the regression‐adjusted change for the treatment group relative to that for the comparison group between the baseline and follow‐up periods. The estimated effect for the binary outcome of any readmission within 30 days of hospital discharge is a regression‐adjusted treatment–comparison difference based on a cross‐sectional regression that controls for a beneficiary's baseline characteristics and discharge‐level risk factors for having a readmission. The follow‐up years are beneficiary‐specific and defined relative to each beneficiary's date of enrollment. Percentage effect is relative to a counterfactual value defined as the regression‐adjusted treatment group mean minus the estimated effect.

Abbreviations: ED, emergency department; eLTC, eLongTermCare; PBPM, per beneficiary per month.

*

Significantly different from zero at the 0.10 level, two‐tailed test.

**

Significantly different from zero at the 0.05 level, two‐tailed test.

***

Significantly different from zero at the 0.01 level, two‐tailed test.